Medical Oncologist Bruno Bastos, M.D., joins Miami Cancer Institute

MIAMI – August 5, 2019 — Miami Cancer Institute at Baptist Health South Florida, the state’s only member of the Memorial Sloan Kettering Cancer Alliance, welcomes medical oncologist and clinical researcher Bruno Bastos, M.D., to its multidisciplinary team of cancer care specialists. Dr. Bastos specializes in the diagnosis and treatment of genitourinary cancer, which includes the prostate, bladder, kidney, ureter and urethra. He has expertise in the use of the most advanced systemic therapies, such as chemotherapy, hormone therapy and targeted therapy, both in the adjuvant and metastatic setting.

Dr. Bastos is triple board certified by the American Board of Internal Medicine in internal medicine, medical hematology and medical oncology and he earned his medical degree at Universidade Federal da Bahia in Salvador, Brazil. He completed a residency in internal medicine and a fellowship in hematology/oncology at University of Miami Miller School of Medicine. He also completed a fellowship in developmental therapeutics in the medical oncology division at Dana-Farber Cancer Institute, which is a principal teaching affiliate of Harvard Medical School in Boston, Mass. Prior to joining Miami Cancer Institute, Dr. Bastos treated patients and conducted research at Cleveland Clinic Florida in Weston.

“We are pleased that Dr. Bastos is bringing his tremendous talents to Miami Cancer Institute,” said Michael J. Zinner, M.D., CEO and executive medical director of Miami Cancer Institute. “He has extensive experience in providing outstanding patient treatment and is actively involved in groundbreaking clinical research to discover new ways to treat cancer and improve patient outcomes.”

Among Dr. Bastos’ many leadership roles in the cancer research field is an appointment by Florida Gov. Rick Scott to the Florida Center for Brain Tumor Research Scientific Advisory Council. His extensive teaching experience includes serving as clinical assistant professor of medicine at Case Western Reserve University School of Medicine. Dr. Bastos is an active member of several professional organizations. He also serves as an editorial reviewer for numerous peer-reviewed medical journals, is widely published in those medical journals and delivers invited lectures at national and international scientific symposiums.

About Miami Cancer Institute
Miami Cancer Institute is a next-generation cancer treatment destination known for its leading clinical care and research, compassionate patient experience and state-of-the-art technology – including the first proton therapy center in South Florida, Latin America and the Caribbean, and the only radiation oncology program in the world with each of the latest radiation therapies in one place. The Institute offers an impressive roster of established community oncologists and renowned cancer experts, clinical researchers and genomic scientists recruited from the nation’s top cancer centers. As Florida’s only member of the Memorial Sloan Kettering (MSK) Cancer Alliance, Miami Cancer Institute is part of a deep and functional collaboration that affords patients access to innovative treatments right here at home and ensures that the standards of care developed by our multidisciplinary disease management teams match those at MSK. Heralded nationally as one of the “hybrid” cancer centers of the future, Miami Cancer Institute combines high-quality community-based cancer care with the best of an academic cancer center, including innovative clinical trials tied to research and genomics and disease-specific surgeons, medical oncologists and radiation oncologists who are experts in their fields. For more information, visit MiamiCancerInstitute.com.

# # #